Leland Gershell
2014 - Tonix Pharmaceuticals Holding
In 2014, Leland Gershell earned a total compensation of $1.3M as Chief Financial Officer at Tonix Pharmaceuticals Holding, a 74% increase compared to previous year.
Compensation breakdown
| Bonus | $97,500 |
|---|---|
| Option Awards | $851,852 |
| Salary | $315,845 |
| Total | $1,265,197 |
Gershell received $851.9K in option awards, accounting for 67% of the total pay in 2014.
Gershell also received $97.5K in bonus and $315.8K in salary.
Rankings
In 2014, Leland Gershell's compensation ranked 6,532nd out of 13,032 executives tracked by ExecPay. In other words, Gershell earned more than 49.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,532 out of 13,032 | 50th |
Division Manufacturing | 2,379 out of 4,966 | 52nd |
Major group Chemicals And Allied Products | 802 out of 1,686 | 52nd |
Industry group Drugs | 628 out of 1,365 | 54th |
Industry Pharmaceutical Preparations | 479 out of 1,043 | 54th |
Source: SEC filing on March 25, 2016.
Gershell's colleagues
We found two more compensation records of executives who worked with Leland Gershell at Tonix Pharmaceuticals Holding in 2014.